VR
Venkata Rambabu Donepudi
About Venkata Rambabu Donepudi
Data last updated:
Venkata Rambabu Donepudi has 6 years in corporate governance. Holds Managing Director role. Currently with 1 company, including Sanjeevani Nutritech Solvents Private Limited. Engaged in Technology. Contributes to corporate operations. The largest current company by reported revenue is Sanjeevani Nutritech Solvents Private Limited at ₹208 Cr (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Managing Director | 05 Aug 2020 | 2020 | ₹208 Cr (FY 2023) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Venkata Rambabu Donepudi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Venkata Rambabu Donepudi
Venkata Rambabu Donepudi has 6 years in corporate governance. Holds Managing Director role. Currently with 1 company, including Sanjeevani Nutritech Solvents Private Limited. Engaged in Technology. Contributes to corporate operations. The largest current company by reported revenue is Sanjeevani Nutritech Solvents Private Limited at ₹208 Cr (FY 2023).
Venkata Rambabu Donepudi is associated with 1 company as Managing Director, including Sanjeevani Nutritech Solvents Private Limited (₹208 Cr).
Venkata Rambabu Donepudi has expertise in Technology.
Venkata Rambabu Donepudi has 6 years in corporate governance.
By reported revenue, the largest current company of Venkata Rambabu Donepudi is Sanjeevani Nutritech Solvents Private Limited, with revenue of ₹208 Cr (FY 2023).
Venkata Rambabu Donepudi currently holds positions at 1 company: Sanjeevani Nutritech Solvents Private Limited (₹208 Cr).